Clinics in Dermatology
Volume 24, Issue 1 , Pages 16-25 , January 2006

Laser-mediated photodynamic therapy

References 

  1. Daniel MD, Hill JS. A history of photodynamic therapy. Aust NZ J Surg. 1991;61:340–348
  2. Pathak MA, Fitzpatrick TB. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J Photochem Photobiol B. 1992;14:3–22
  3. Wilson BT, Mang T. Photodynamic therapy for cutaneous malignancies. Clin Dermatol. 1995;13:91–96
  4. Lui H, Bissonnette R. Photodynamic therapy. In:  Goldman M,  Fitzpatrick R editor. Cutaneous laser surgery. St. Louis (Mo): Mosby; 1999;p. 437–458
  5. Raab O. Ueber die Wirkung Fluroescierenden Stoffe auf Infusorien. Z Biol. 1900;39:524–546
  6. Von Tappeiner H, Jesionek A. Therapeutische Versuche mit fluorescierenden Stoffen. Much Med Wochenschr. 1903;47:2042–2044
  7. Von Tappeiner H, Jodlbauer A. Ueber wirkung der photodynamischen (fluorescierenden) Stoffe auf Protozoan und Enzyme. Dtsch Arch Klin Med. 1904;80:427–487
  8. Von Tappiner H, Jodlbauer A. Die Sensibilisierende Wirkung Fluroescierender Substanzer, Basammette Untersuchungen Uber die Photodynamische Erscheinung. Leipzig: FCW Vogel; 1907;
  9. Meyer-Betz F. Untersuchungen uber die Biologische (photodynamische) wirkung des hamatopophyrins und anderer derivative des Blut-und Gallenfarbstoffs. Dtsch Arch Klin Med. 1913;112:476
  10. Auler H, Banzer G. Untersucheungen uber die rolle der porphyrine bei geschwulstkranken menschen und tieren. Z Krebsforsch. 1942;53:65
  11. Figge FHJ, Wiland GS, Manganiello LOJ. Cancer detection and therapy: affinity of neoplastic, embryonic and traumatized tissues for porphyrins and metallopophyrins. Proc Soc Exp Biol Med. 1948;68:640–641
  12. Malik Z, Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer. 1987;56:589–595
  13. Kennedy JC, Pottier Rh, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B. 1990;14:275–292
  14. Alexiades-Armenakas MR, Geronemus G. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol. 2003;139:1313–1320
  15. Soret JL. Recherches sur l’absorption des rayons ultra violets par diverses substances. Arch Sci Phys Nat. 1883;10:430–485
  16. Kurwa HA, Barlow RJ. The role of photodynamic therapy in dermatology. Clin Exp Dermatol. 1999;24:143–148
  17. Pottier RH, Chow YFA, LaPlante J-P, et al. Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol. 1986;44:679–687
  18. Anderson RR. Laser-tissue interactions. In:  Goldman MP,  Fitzpatrick RE editor. Cutaneous laser surgery. 2nd ed.. St. Louis (Mo): Mosby; 1999;p. 5
  19. Wilson BT. The physics of photodynamic therapy. Phys Med Biol. 1986;31:327–360
  20. Driver I, Lowdell CP, Ash DV. In vivo measurements of the optical interaction coefficients of human tumours. Phys Med Biol. 1991;36:805–813
  21. Frazier CC. Photodynamic therapy in dermatology. Int J Dermatol. 1996;35:312–316
  22. Lipson RL, Baldes EJ, Olsen AM. The use of a derivative of haematoporphyrin in tumour detection. J Natl Cancer Inst. 1961;26:1
  23. Lipson RL, Baldes EJ, Gray MJ. Hematopophyrin derivative for detection and management of cancer. Cancer. 1967;20:2255
  24. Dougherty TJ, Grindley GB, Fiel R, Weishaupt KR, Boyle DG. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst. 1975;55:115–121
  25. Dougherty TJ, Kaugman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumours. Cancer Res. 1978;38:2628–2635
  26. McCaughan JS, Guy JT, Hawley P, et al. Hamatoporphyrin-derivative and photoradiation therapy of malignant tumors. Lasers Surg Med. 1983;3:199–209
  27. Szeimies RM, Hein R, Baumler W, Heine A, Landthaler M. A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol. 1994;74:117–119
  28. Collins P, Robinson DJ, Stringer MR, et al. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1997;137:743–749
  29. Morton CA, Whitehurst C, Moseley H, et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol. 1996;135:766–771
  30. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J Am Acad Dermatol. 1993;28:17–21
  31. Lui H, Salasche S, Kollias AT, et al. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical histologic study. Arch Dermatol. 1995;131:737–738
  32. Orenstein A, Kostenich G, Tsur H, et al. Photodynamic therapy of human skin tumors using topical application of 5-aminolevulinic acid, DMSO and EDTA. In:  Brault D,  Jori G,  Moan J,  Ehrenberg B editor. Photodynamic therapy of cancer II. Proc SPIE. vol 2325:1995;p. 100–105
  33. Fijan S, Honignsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolevulinic acid and desferrioxamine. Br J Dermatol. 1995;133:282–288
  34. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol. 2001;45:96–104
  35. Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol. 2004;140:41–46
  36. Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004;140:33–40
  37. Goldman MP, Boyce S. A single-center study of aminolevulinic acid and 417 nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J Drugs Dermatol. 2003;2:393–396
  38. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate–based photodynamic therapy alone and with prior curettage. Br J Dermatol. 2001;145:467–471
  39. Rhodes LE, de Rie M, Enstrom Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs. surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140:17–23
  40. Vincullo C, Elliot T, Francis D, et al. Photodynamic therapy with topical methyl aminolaevulinate for “difficult-to-treat” basal cell carcinoma. Br J Dermatol. 2005;152:765–772
  41. Szeimes RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5–aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol. 2002;47:258–262
  42. Parisar DM, Lowe NJ, Steward DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003;48:227–232
  43. Lui H, Anderson RR. Photodynamic therapy in dermatology: recent developments. Dermatol Ther. 1993;11:1–13
  44. Bandieramonte G, Marchesini R, Melloni E, et al. Laser phototherapy following HpD administration in superficial neoplastic lesions. Tumori. 1984;70:327–334
  45. Lui H, Hobbs L, Tope W, et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light–emitting diodes: two-year response and cosmetic outcomes. Arch Dermatol. 2004;140:26–32
  46. Warloe T, Peng Q, Moan J, Qvist HL, Giercksky KE. Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid. In:  Spinelli P,  Fante MD,  Marchesini R editor. Photodynamic therapy and biomedical lasers. Amsterdam: Elsevier Science Publishers BV; 1992;p. 436–440
  47. Warloe T, Peng Q, Heyerdahl H, et al. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. In:  Cortese DA editors. 5th ed.. International Photodynamic Association Bienniel Meeting. Proc SPIE. vol 2371:1995;p. 226–235
  48. Svanberg K, Andersson T, Killander D. Photodynamic therapy of human skin malignancies and laser-induced fluorescence diagnostics utilizing photofrin and delta-aminolevulinic acid. In:  Spinelli P,  Fante MD,  Marchesini R editor. Photodynamic therapy and biomedical lasers. Amsterdam: Elsevier Science Publishers BV; 1992;p. 436–440
  49. Svanberg K, Andersson T, Killander D, et al. Photodynamic therapy of non-melanoma malignant tumors of the skin using topical delta-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol. 1994;130:743–751
  50. Calzavara-Pinton PG. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumors. J Photochem Photobiol B. 1995;29:53–57
  51. Jeffes EW, McCullough JL, Weinstein GD, et al. Photodynamic therapy of actinic keratoses with topical 5-aminolevulinic acid: a pilot dose-ranging study. Arch Dermatol. 1997;133:727–732
  52. Peng Q, Warloe T, Berg K, et al. 5-aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer. 1997;79:2282–2308
  53. Oseroff A, Shieh S, Frawley NP, et al. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Arch Dermatol. 2004;141:60–67
  54. Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115:183–192
  55. Pollock B, Turner D, Stringer MR, et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol. 2004;151:616–622
  56. Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142:973–978
  57. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol. 2000;136:1093–1095
  58. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta aminolevulinic acid and incoherent light in Japanese patients. Br J Dermatol. 2001;144:575–579
  59. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy and photodiagnosis using endogenous photosensitization induced by 5-aminolevulinic acid: mechanisms and clinical results. J Clin Laser Med Surg. 1996;14:289–304
  60. Karrer S, Baumler W, Abels C, et al. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med. 1999;25:51–59
  61. Alam M, Dover JS. Treatment of photoaging with topical aminolevulinic acid and light. Skin Ther Lett. 2004;3:548–551
  62. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol. 2004;3:548–552
  63. Lee WL, Shalita AR, Poh-Fitzpatrick MB. Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum. J Bacteriol. 1978;133:811–815
  64. Arakane K, Rya A, Hayashi C, et al. Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation. Biochem Biophys Res Commun. 1996;223:578–582
  65. Divaris DX, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol. 1990;136:891–897
  66. Alexiades-Armenakas MR, Bernstein L, Chen J, Jacobson L, Geronemus R. Laser-assisted photodynamic therapy of acne vulgaris and related conditions. Am Soc Las Surg Med Abstr Anaheim. 2003;
  67. Alster TS, Tanzi EL. Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol. 2003;2:501–504
  68. Alexiades-Armenakas MR. Safety and efficacy of long-pulsed, pulsed dye laser-mediated photodynamic therapy in patients with mild to severe comedonal, inflammatory, or cystic acne. J Drugs Dermatol. 2006;5(1):
  69. Seaton ED, Charakida A, Mouser PE, et al. Pulsed-dye laser treatment for inflammatory acne vulgaris: randomized controlled trial. Lancet. 2003;362:1342
  70. Orringer JS, Kang S, Hamilton T, et al. Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial. JAMA. 2004;291:2834–2839
  71. Hillemanns P, Untch M, Prove F, et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol. 1999;93:71–74
  72. Alexiades-Armenakas MR. Laser-mediated photodynamic therapy of lichen sclerosus. J Drugs Dermatol. 2004;3(6 Suppl):S25–S27
  73. Evans AV, Robson A, Barlow RJ, Kurwa HA. Treatment of port wine stains with photodynamic therapy, using pulsed dye laser as a light source, compared with pulsed dye laser alone: a pilot study. Lasers Surg Med. 2005;36:266–269
  74. Kelly KM, Kimel S, Smith T, et al. Combined photodynamic and photothermal induced injury enhances damage to in vivo model blood vessels. Lasers Surg Med. 2004;34:407–413
  75. Smucler R, Jatsova E. Comparative study of aminolevulinic acid photodynamic therapy plus pulsed dye laser versus pulsed dye laser alone in treatment of viral warts. Photomed Laser Surg. 2005;23:202–205
  76. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamic photorejuvenation. Dermatol Surg. 2002;28:742–744
  77. Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol. 2004;3(1 Suppl):S36–S39
  78. Gilbert DJ. Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy. J Drugs Dermatol. 2005;4:161–163
  79. Kim HS, Yoo JY, Cho KH, Kwon OS, Moon SE. Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: clinical and histopathologic evaluation. Dermatol Surg. 2005;31:33–36[discussion 36-7]
  80. Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol. 2005;4:35–38
  81. Hall JA, Keller PJ, Keller GS. Dose response of combination photorejuvenation using intense pulsed light-activated photodynamic therapy and radiofrequency energy. Arch Facial Plast Surg. 2004;6:374–378
  82. Ashish B, Dover J, Stewart B, Arndt K. Topical aminolevulinic acid with intense pulsed light in the treatment of photoaging. Am Soc Las Med Surg Abst. 2005;(Suppl 17):26
  83. Gold MH, Bradshaw VL, Boring MM, et al. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J Drugs Dermatol. 2004;3(6 Suppl):S15–S19
  84. Taub AF. Photodynamic therapy for the treatment of acne: a pilot study. J Drugs Dermatol. 2004;3(Suppl 6):S10–S14

PII: S0738-081X(05)00153-7

doi: 10.1016/j.clindermatol.2005.10.027

Clinics in Dermatology
Volume 24, Issue 1 , Pages 16-25 , January 2006

Article Tools

* Image Usage & Resolution